Bisnorcymserine manufacturers
- Bisnorcymserine
-
- $3100.00
-
2026-05-11
- CAS:219920-81-7
- Purity:
- Supply Ability: 10g
|
| | Bisnorcymserine Basic information |
| Product Name: | Bisnorcymserine | | Synonyms: | Bisnorcymserine;Carbamic acid, N-[4-(1-methylethyl)phenyl]-, (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-3a-methylpyrrolo[2,3-b]indol-5-yl ester;N1 N8 Bisnorcymserine;N1N8Bisnorcymserine;N1-N8-Bisnorcymserine | | CAS: | 219920-81-7 | | MF: | C21H25N3O2 | | MW: | 351.44 | | EINECS: | | | Product Categories: | | | Mol File: | 219920-81-7.mol |  |
| | Bisnorcymserine Chemical Properties |
| Boiling point | 491.2±45.0 °C(Predicted) | | density | 1.192±0.06 g/cm3(Predicted) | | pka | 13.02±0.70(Predicted) |
| | Bisnorcymserine Usage And Synthesis |
| Uses | Bisnorcymserine ((-)-Bisnorcymserine) is an inhibitor for butyrylcholinesterase (BChE) with an IC50 of 0.228 nM. Bisnorcymserine reduces the levels of amyloid-β peptide (Aβ), exhibits ameliorates the Alzheimer’s Disease in elderly rat models. Bisnorcymserine is blood-brain barrier penetrate[1]. | | IC 50 | BChE: 0.228 nM (IC50) | | References | [1] Kamal MA, et al., Kinetics of human serum butyrylcholinesterase and its inhibition by a novel experimental Alzheimer therapeutic, bisnorcymserine. J Alzheimers Dis. 2006 Sep;10(1):43-51. DOI:10.3233/jad-2006-10108 |
| | Bisnorcymserine Preparation Products And Raw materials |
|